Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Successful Treatment for Refractory Interstitial Lung Disease and Pneumomediastinum With Multidisciplinary Therapy Including Tofacitinib in a Patient With Anti-MDA5 Antibody-Positive Dermatomyositis.

× No keyword cloud information.

7 in total

1. Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib.

Authors: Sara Sabbagh; Adriana Almeida de Jesus; SuJin Hwang; Hye Sun Kuehn; Hanna Kim; Lawrence Jung; Ruy Carrasco; Sergio Rosenzweig; Raphaela Goldbach-Mansky; Lisa G Rider
Journal: Brain Date: 2019-11-01 Impact factor: 13.501

Review 2. Antisynthetase syndrome: A distinct disease spectrum.

Authors: Kun Huang; Rohit Aggarwal
Journal: J Scleroderma Relat Disord Date: 2020-02-18

3. Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies.

Authors: Hanna Kim; Fatima Gunter-Rahman; John A McGrath; Esther Lee; Adriana A de Jesus; Ira N Targoff; Yan Huang; Terrance P O'Hanlon; Wanxia L Tsai; Massimo Gadina; Frederick W Miller; Raphaela Goldbach-Mansky; Lisa G Rider
Journal: Arthritis Res Ther Date: 2020-04-06 Impact factor: 5.156

4. Iacta Alea Est: The Inexorable Advance of Tofacitinib in the Treatment of Dermatomyositis-Associated Rapidly Progressive Interstitial Lung Disease. A Case Report.

Authors: Walter Conca; Ihab Weheba; Mohei-Eldin Abouzied; Abeer Abdelsayed; Yousif Aleyouni; Eid Al-Mutairy; Nasir Bakshi; Mohammad Khalid
Journal: Front Pharmacol Date: 2020-12-15 Impact factor: 5.810

Review 5. Management of Myositis-Associated Interstitial Lung Disease.

Authors: Tomoyuki Fujisawa
Journal: Medicina (Kaunas) Date: 2021-04-03 Impact factor: 2.430

Review 6. Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows.

Authors: Giulia Cassone; Andreina Manfredi; Caterina Vacchi; Fabrizio Luppi; Francesca Coppi; Carlo Salvarani; Marco Sebastiani
Journal: J Clin Med Date: 2020-04-10 Impact factor: 4.241

7. A retrospective comparison of respiratory events with JAK inhibitors or rituximab for rheumatoid arthritis in patients with pulmonary disease.

Authors: Owen Cronin; Olivia McKnight; Lindsay Keir; Stuart H Ralston; Nikhil Hirani; Helen Harris
Journal: Rheumatol Int Date: 2021-03-15 Impact factor: 2.631

7 in total